Apropos: factors impacting on progress towards elimination of transmission of schistosomiasis japonica in China

Particle and Fibre Toxicology

You-Sheng Liang¹  Jian-Rong Dai¹  Wei Wang¹ 

[1] Jiangsu Provincial Key Laboratory of Molecular Biology of Parasites, 117 Yangxiang, Meiyuan, Wuxi City, Jiangsu Province 214064, People’s Republic of China

关键词: China;    Elimination;    Schistosomiasis;   

Others  :  1150674
DOI  :  10.1186/1756-3305-7-408

 received in 2014-07-23, accepted in 2014-08-24,  发布年份 2014

【 摘 要 】

Currently, China is moving towards the elimination of schistosomiasis japonica. In a previous review, the factors affecting the progress towards the elimination of transmission of schistosomiasis in China have been summarized. Nevertheless, some factors were neglected. Hereby, we describe four other factors which may threaten the achievement of the goal of schistosomiasis elimination in China.

【 授权许可】

   
2014 Wang et al.; licensee BioMed Central Ltd.

【 参考文献 】

• [1]Yang GJ, Liu L, Zhu HR, Griffiths SM, Tanner M, Bergquist R, Utzinger J, Zhou XN: China's sustained drive to eliminate neglected tropical diseases. Lancet Infect Dis 2014. in press
• [2]Zhou XN, Bergquist R, Leonardo L, Yang GJ, Yang K, Sudomo M, Olveda R: Schistosomiasis japonica control and research needs. Adv Parasitol 2010, 72:145-178.
• [3]Collins C, Xu J, Tang S: Schistosomiasis control and the health system in P.R. China. Infect Dis Poverty 2012, 1:8. BioMed Central Full Text
• [4]Zhou YB, Liang S, Jiang QW: Factors impacting on progress towards elimination of transmission of schistosomiasis japonica in China. Parasit Vectors 2012, 5:275. BioMed Central Full Text
• [5]Wang L, Utzinger J, Zhou XN: Schistosomiasis control: experiences and lessons from China. Lancet 2008, 372:1793-1795.
• [6]Hipgrave D: Communicable disease control in China: From Mao to now. J Glob Health 2011, 1:224-238.
• [7]Xianyi C, Liying W, Jiming C, Xiaonong Z, Jiang Z, Jiagang G, Xiaohua W, Engels D, Minggang C: Schistosomiasis control in China: the impact of a 10-year World Bank Loan Project (1992–2001). Bull World Health Organ 2005, 83:43-48.
• [8]Zhou XN, Wang LY, Chen MG, Wu XH, Jiang QW, Chen XY, Zheng J, Utzinger J: The public health significance and control of schistosomiasis in China–then and now. Acta Trop 2005, 96:97-105.
• [9]Wu XH, Chen MG, Zheng J: Surveillance of schistosomiasis in five provinces of China which have reached the national criteria for elimination of the disease. Acta Trop 2005, 96:276-281.
• [10]Liang S, Yang C, Zhong B, Qiu D: Re-emerging schistosomiasis in hilly and mountainous areas of Sichuan, China. Bull World Health Organ 2006, 84:139-144.
• [11]Berry-Cabán CS: Return of the God of Plague: Schistosomiasis in China. J Rural Trop Public Health 2007, 6:45-53.
• [12]Wang LD, Chen HG, Guo JG, Zeng XJ, Hong XL, Xiong JJ, Wu XH, Wang XH, Wang LY, Xia G, Hao Y, Chin DP, Zhou XN: A strategy to control transmission of Schistosoma japonicum in China. N Engl J Med 2009, 360:121-128.
• [13]Chen YY, Liu JB, Huang XB, Cai SX, Su ZM, Zhong R, Zou L, Miao XP: New integrated strategy emphasizing infection source control to curb Schistosomiasis japonica in a marshland area of Hubei Province China: findings from an eight-year longitudinal survey. PLoS One 2014, 9:e89779.
• [14]Liu R, Dong HF, Jiang MS: The new national integrated strategy emphasizing infection sources control for schistosomiasis control in China has made remarkable achievements. Parasitol Res 2013, 112:1483-1491.
• [15]Hong XC, Xu XJ, Chen X, Li YS, Yu CH, Yuan Y, Chen YY, Li RD, Qiu J, Liu ZC, Yi P, Ren GH, He HB: Assessing the effect of an integrated control strategy for schistosomiasis japonica emphasizing bovines in a marshland area of Hubei Province China: a cluster randomized trial. PLoS Negl Trop Dis 2013, 7:e2122.
• [16]Li SZ, Zheng H, Gao J, Zhang LJ, Zhu R, Xu J, Guo JG, Xiao N, Zhou XN: Endemic status of schistosomiasis in People's Republic of China in 2012. Chin J Schisto Control 2013, 25:557-563. In Chinese
• [17]Fan KW: Central-provincial relations for anti-schistosomiasis policy in China. Iran J Public Health 2012, 41:1-11.
• [18]Githeko AK, Lindsay SW, Confalonieri UE, Patz JA: Climate change and vector-borne diseases: a regional analysis. Bull World Health Organ 2000, 78:1136-1147.
• [19]Kilpatrick AM, Randolph SE: Drivers, dynamics, and control of emerging vector-borne zoonotic diseases. Lancet 2012, 380:1946-1955.
• [20]Mas-Coma S, Valero MA, Bargues MD: Climate change effects on trematodiases, with emphasis on zoonotic fascioliasis and schistosomiasis. Vet Parasitol 2009, 163:264-280.
• [21]McCreesh N, Booth M: Challenges in predicting the effects of climate change on Schistosoma mansoni and Schistosoma haematobium transmission potential. Trends Parasitol 2013, 29:548-555.
• [22]Liang YS, Wang W, Li HJ, Shen XH, Xu YL, Dai JR: The South-to-North Water Diversion Project: effect of the water diversion pattern on transmission of Oncomelania hupensis, the intermediate host of Schistosoma japonicum in China. Parasit Vectors 2012, 5:52. BioMed Central Full Text
• [23]Zhou XN, Yang GJ, Yang K, Wang XH, Hong QB, Sun LP, Malone JB, Kristensen TK, Bergquist NR, Utzinger J: Potential impact of climate change on schistosomiasis transmission in China. Am J Trop Med Hyg 2008, 78:188-194.
• [24]Yang GJ, Vounatsou P, Zhou XN, Tanner M, Utzinger J: A potential impact of climate change and water resource development on the transmission of Schistosoma japonicum in China. Parassitologia 2005, 47:127-134.
• [25]Doenhoff MJ, Kusel JR, Coles GC, Cioli D: Resistance of Schistosoma mansoni to praziquantel: is there a problem? Trans R Soc Trop Med Hyg 2002, 96:465-469.
• [26]Couto FF, Coelho PM, Araújo N, Kusel JR, Katz N, Jannotti-Passos LK, Mattos AC: Schistosoma mansoni: a method for inducing resistance to praziquantel using infected Biomphalaria glabrata snails. Mem Inst Oswaldo Cruz 2011, 106:153-157.
• [27]Melman SD, Steinauer ML, Cunningham C, Kubatko LS, Mwangi IN, Wynn NB, Mutuku MW, Karanja DM, Colley DG, Black CL, Secor WE, Mkoji GM, Loker ES: Reduced susceptibility to praziquantel among naturally occurring Kenyan isolates of Schistosoma mansoni. PLoS Negl Trop Dis 2009, 3:e504.
• [28]Zhou YB, Zhao GM, Jiang QW: Effects of the praziquantel-based control of schistosomiasis japonica in China. Ann Trop Med Parasitol 2007, 101:695-703.
• [29]Seto EY, Wong BK, Lu D, Zhong B: Human schistosomiasis resistance to praziquantel in China: should we be worried? Am J Trop Med Hyg 2011, 85:74-82.
• [30]Wang W, Dai JR, Li HJ, Shen XH, Liang YS: Is there reduced susceptibility to praziquantel in Schistosoma japonicum? Evidence from China. Parasitology 2010, 137:1905-1912.
• [31]Wang W, Dai JR, Li HJ, Shen XH, Liang YS: The sensitivity of Schistosoma japonicum to praziquantel: a field evaluation in areas with low endemicity of China. Am J Trop Med Hyg 2012, 86:834-836.
• [32]Wang W, Wang L, Liang YS: Susceptibility or resistance of praziquantel in human schistosomiasis: a review. Parasitol Res 2012, 111:1871-1877.
• [33]Wang W, Li HJ, Qu GL, Xing YT, Yang ZK, Dai JR, Liang YS: Is there a reduced sensitivity of dihydroartemisinin against praziquantel-resistant Schistosoma japonicum? Parasitol Res 2014, 113:223-228.
• [34]Attwood SW, Huo GN, Qiu JW: Update on the distribution and phylogenetics of Biomphalaria (Gastropoda: Planorbidae) populations in Guangdong Province, China. Acta Trop 2014. in press
• [35]Lu P, Wang W, Dai J, Liang Y: Imported African schistosomiasis: is it an emerging public health concern in China? J Travel Med 2014, 21:72-73.
• [36]Wang W, Liang YS, Hong QB, Dai JR: African schistosomiasis in mainland China: risk of transmission and countermeasures to tackle the risk. Parasit Vectors 2013, 6:249. BioMed Central Full Text